Data gathered: December 1
Data Bits
Data Bits | Value / Change | Benchmark | |
---|---|---|---|
Job Posts | 117 -3.3% |
|
|
Sentiment | 86 -1.1% |
|
|
Webpage traffic | 41,000 43.9% |
|
|
Employee Rating | 83 0% |
|
|
Google Adspend | $2,306 692.4% |
|
|
Google Trends | 0% |
|
|
Linkedin Employees | 3,239 N/A |
|
|
Patents | 73 0% |
|
|
4chan Mentions | 0% |
|
|
Facebook Engagement | 3 50% |
|
|
Facebook followers | 6,038 0% |
|
|
Stocktwits Mentions | 2 100% |
|
|
Stocktwits Subscribers | 5,037 -0.1% |
|
|
Youtube Subscribers | 1,330 0% |
|
|
Instagram Followers | 4,219 N/A | N/A | |
News Mentions | -100% |
|
|
Reddit Mentions | 0% |
|
|
Business outlook | 79 0% |
|
In the news
Analysts Are Bullish on These Healthcare Stocks: UnitedHealth (UNH), Alnylam Pharma (ALNY)November 29 - TipRanks |
|
Elfun Trusts Sheds Qualcomm in Q3, Embraces New HoldingsNovember 29 - Yahoo |
|
Non-Oncology Biologics and Biosimilars Market is Booming and Expected to Grow at a CAGR of 21.8% to 2031November 29 - GlobeNewswire |
|
![]() |
Pro Research: Wall Street eyes BioMarin's strategic growthNovember 28 - Investing.com |
![]() |
BioMarin secures hemophilia gene therapy coverage in GermanyNovember 28 - Yahoo |
BioMarin Announces Agreement with German Health Insurance Fund on Reimbursement Amount for ROCTAVIAN for Severe Hemophilia A in GermanyNovember 28 - Finnhub |
About Biomarin Pharmaceutical
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions.

Price | $92.19 |
Target Price | Sign up |
Market Cap | $16.9B |
Dividend Yield | 0.0371 |
Industry | Biotechnology |
Similar companies
Financial performance View All
Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | |
---|---|---|---|---|---|
Q3 '23 | 578M | 125M | 453M | 40M | 71M |
Q2 '23 | 592M | 128M | 463M | 56M | 100M |
Q1 '23 | 586M | 127M | 460M | 51M | 87M |
Q4 '22 | 506M | 127M | 379M | -250,000 | 11M |
Q3 '22 | 501M | 116M | 384M | -6.7M | 28M |
Insider Transactions
Ajer Jeffrey Robert filed to sell 60,804 shares at $90. August 17 '23 |
FUCHS HENRY J filed to sell 176,187 shares at $90.4. August 11 '23 |
Guyer Charles Greg filed to sell 40,041 shares at $93.3. August 10 '23 |
BIENAIME JEAN JACQUES filed to sell 422,732 shares at $88.3. August 9 '23 |
Davis George Eric filed to sell 69,474 shares at $89.4. August 9 '23 |